{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:00:47Z","timestamp":1771920047614,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary clear cell adenocarcinoma of the urethra (PCCAU) is an extremely rare malignant tumor. Its clinical manifestations are nonspecific, and preoperative diagnosis relies primarily on imaging studies. To date, most reports on this disease are isolated case presentations, and systematic studies correlating imaging findings with pathological results remain scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 58-year-old woman was admitted due to voiding dysfunction for 14 months, worsened with gross hematuria for 2 months. Preoperative imaging evaluation included ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI). US revealed an irregular hypoechoic mass in the post-bladder urethral region with minimal internal blood flow; CT scan indicated a heterogeneously enhancing mass in the urethral area accompanied by necrotic changes; MRI demonstrated a periurethral lesion showing a slightly high signal on T2-weighted imaging (T2WI) with a low-signal capsule. Diffusion-weighted imaging (DWI) showed restricted diffusion, with an apparent diffusion coefficient (ADC) value of 0.79 \u00d7 10\n                      <jats:sup>-<\/jats:sup>\n                      \u00b3 mm\u00b2\/s, heterogeneous enhancement in the arterial phase of dynamic contrast-enhanced imaging, and a centripetal filling pattern. Postoperative histopathology confirmed the diagnosis of PCCAU. Immunohistochemical findings were as follows: AE1\/AE3 (+), CK7 (focal +), PAX8 (+), P504S (+), Napsin A (scant +), p53 (~5%+), and Ki-67 (~35%+). The patient declined adjuvant therapy after surgery. Seven months postoperatively, she developed lymph node metastasis and peristomal metastasis around the right ureteral abdominal wall orifice, and was subsequently treated with toripalimab immunotherapy. She remained alive at the 1-year postoperative follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PCCAU is extremely rare. Imaging examinations, particularly multimodal MRI, combined with histopathological and immunohistochemical analyses, play a crucial role in its diagnosis. Early surgical intervention contributes to improved prognosis, and personalized treatment strategies, including immunotherapy, may offer clinical benefits in advanced cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1708651","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:19:02Z","timestamp":1771910342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Primary clear cell adenocarcinoma of the urethra\u2014imaging features and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Li","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Radiology, Gejiu People\u2019s Hospital","place":["Gejiu, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Radiology, Gejiu People\u2019s Hospital","place":["Gejiu, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiology, Gejiu People\u2019s Hospital","place":["Gejiu, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Gejiu People\u2019s Hospital","place":["Gejiu, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaichuang","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Radiology, Gejiu People\u2019s Hospital","place":["Gejiu, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuixian","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Gejiu People\u2019s Hospital","place":["Gejiu, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Gejiu People\u2019s Hospital","place":["Gejiu, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"B1","unstructured":"EAU Guidelines on Primary Urethral Carcinoma\n          \n          \n          2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2017.10.017","article-title":"Female urethra adenocarcinoma","volume":"16","author":"Dell\u2019Atti","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00428-012-1363-3","article-title":"Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems","volume":"462","author":"Alexiev","year":"2013","journal-title":"Virchows Arch"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/790235","article-title":"Clear cell adenocarcinoma of the urethra: review of the literature","volume":"2015","author":"Venyo","year":"2015","journal-title":"Int J Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1539312","article-title":"Two rare cases of primary clear cell adenocarcinoma of the urethra: clinical experience, case report and literature review","volume":"15","author":"Jiang","year":"2025","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1148\/rg.24si045504","article-title":"Imaging of urethral disease: a pictorial review","author":"Kawashima","year":"2004","journal-title":"Radiographics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bju.12564","article-title":"Management of advanced primary urethral carcinomas","volume":"114","author":"Gakis","year":"2014","journal-title":"BJU Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198511000-00005","article-title":"Clear cell adenocarcinoma of the bladder and urethra","volume":"9","author":"Young","year":"1985","journal-title":"Am J Surg Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/uog.3988","article-title":"Two- and three-dimensional transvaginal Doppler ultrasound analysis of urethral clear cell carcinoma","volume":"29","author":"Tsai","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.226734","article-title":"Clear cell adenocarcinoma of the urethra with inguinal lymph node metastases: A rare case report and review of literature","volume":"14","author":"Mallya","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2023.12.205","article-title":"Primary clear-cell adenocarcinoma surrounding the female urethra: A case report and review of literature","volume":"47","author":"Chen","year":"2024","journal-title":"Asian J Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.138.3.582","article-title":"Carcinoma in diverticulum of the female urethra","volume":"138","author":"Tines","year":"1982","journal-title":"AJR Am J Roentgenol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-199511000-00032","article-title":"MR and CT appearance of urethral clear cell adenocarcinoma in a woman","volume":"19","author":"Morikawa","year":"1995","journal-title":"J Comput Assist Tomogr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/RCT.0b013e318182b0e4","article-title":"Clear cell adenocarcinoma of the female urethra: magnetic resonance imaging","volume":"33","author":"Takeuchi","year":"2009","journal-title":"J Comput Assist Tomogr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.16.16929","article-title":"Clear cell adenocarcinoma of the urethra in women: distinctive MRI findings for differentiation from nonadenocarcinoma and non-clear cell adenocarcinoma of the urethra","volume":"208","author":"Kim","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5858\/2008-132-1417-CCAOUBA","article-title":"Clear cell adenocarcinoma of urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S","volume":"132","author":"Sun","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02289-w","article-title":"The epidemiology and role of surgery in the treatment of urethral clear cell carcinoma","volume":"52","author":"Patel","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"B18","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer. Version 1.2026\n          \n          \n          \n          2026"},{"key":"B19","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer. Version 3.2025\n          \n          \n          \n          2025"},{"key":"B20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1056\/NEJMc2407267","article-title":"Perioperative Nivolumab in resectable lung cancer","volume":"391","author":"Sorscher","year":"2024","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12905-022-01835-6","article-title":"Primary clear cell adenocarcinoma of female urinary tract: a case report and literature review","volume":"22","author":"Miao","year":"2022","journal-title":"BMC Womens Health"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v11.i4.243","article-title":"Personalized chemotherapy in clear cell adenocarcinoma of the urethra: A case report","volume":"11","author":"Shields","year":"2020","journal-title":"World J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1708651\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:19:05Z","timestamp":1771910345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1708651\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":22,"alternative-id":["10.3389\/fonc.2026.1708651"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1708651","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"article-number":"1708651"}}